995 resultados para 37.016:159.922.1
Resumo:
Collection : Les archives de la Révolution française ; 3.1
Resumo:
Commençant par : « Estant couché soubz ung myrthe plaisant, Et maintz chasteaulx en Espaigne faisant... » et finissant par : « Sans parage ou riens n'est nect, Moulu d'un groz Moulinet. Fin de la complaincte de Grece, composée par le dict Molinet » .
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
The aim of this study was to compare wild boar (chromosomal number 2n = 36) to phenotypically similar animals of 2n = 37 and 2n = 38 chromosomes (crossbreeds) with respect to live weight, carcass yield, meat yield, fat and weight of inner organs. All animals were born and raised on the same farm and slaughtered at 39 weeks. The final live weight of wild boar 2n = 36 was significantly lower (47.2 kg) as compared to crossbreeds (80.0 kg). Animals 2n = 36 had more carcass yields (65.5%) than 2n = 37 karyotype (64.9%) and 2n = 38 (64.4%). Wild boar had the highest yields for the cuts with bones and boneless cuts compared to crossbreeds. Therefore, variations in karyotype are accompanied by differences in some carcass quantitative traits, i.e., 2n = 36 grow and fatten slower than crossbreeds 2n = 37 and 2n = 38. (c) 2008 Elsevier Ltd. All rights reserved.
Resumo:
BACKGROUND: The utility of chemotherapy for women who experience a locoregional recurrence after primary treatment of early breast cancer remains an open question. An international collaborative trial is being conducted by the Breast International Group (BIG), the International Breast Cancer Study Group (IBCSG), and the National Surgical Adjuvant Breast and Bowel Project (NSABP) to determine the effectiveness of cytotoxic therapy for these patients, either alone or in addition to selective use of hormonal therapy and trastuzumab. METHODS: The trial population includes women who have had a previous diagnosis of invasive breast cancer treated by mastectomy or breast-conserving surgery, but subsequently develop an isolated local and/or regional ipsilateral invasive recurrence. Excision of all macroscopic tumor without evidence of systemic disease is required for study entry. Patients are randomized to receive chemotherapy or no chemotherapy; type of chemotherapy is not protocol-specified. Radiation, hormonal therapy, and trastuzumab are given as appropriate. The primary endpoint is disease-free survival (DFS). Quality-of-life measurements are collected at baseline, and then at 9 and 12 months. The accrual goal is 977 patients. RESULTS: This report describes the characteristics of the first 99 patients. Sites of recurrence at study entry were: breast (56%), mastectomy scar/chest wall (35%), and regional lymph nodes (9%). Two-thirds of patients have estrogen-receptor-positive recurrences. CONCLUSION: This is the only trial actively investigating the question of "adjuvant" chemotherapy in locally recurrent breast cancer. The case mix of accrual to date indicates a broad representation of this patient population.
Resumo:
In this phase III, multinational, randomized trial, the International Breast Cancer Study Group, Breast International Group, and the National Surgical Adjuvant Breast and Bowel Project will attempt to define the effectiveness of cytotoxic therapy for patients with locoregional recurrence of breast cancer. We will evaluate whether chemotherapy prolongs disease-free survival and, secondarily, whether its use improves overall survival and systemic disease-free survival. Quality of life measurements will be monitored during the first 12 months of the study. Women who have had a previous diagnosis of invasive breast cancer treated by mastectomy or breast-conserving surgery and who have undergone complete surgical excision of all macroscopic disease but who subsequently develop isolated local and/or regional ipsilateral invasive recurrence are eligible. Patients are randomized to observation/no adjuvant chemotherapy or to adjuvant chemotherapy; all suitable patients receive radiation, hormonal, and trastuzumab therapy. Radiation therapy is recommended for patients who have not received previous adjuvant radiation therapy but is required for those with microscopically positive margins. The radiation field must encompass the tumor bed plus a surrounding margin to a dose of >or= 40 Gy. Radiation therapy will be administered before, during, or after chemotherapy. All women with estrogen receptor-positive and/or progesterone receptor-positive recurrence must receive hormonal therapy, with the agent and duration to be determined by the patient's investigator. Adjuvant trastuzumab therapy is permitted for those with HER2- positive tumors, provided that intent to treat is declared before randomization. Although multidrug regimens are preferred, the agents, doses, and use of supportive therapy are at the discretion of the investigator.
Resumo:
1 Brief von Margot von Mendelssohn an Max Horkheimer, 20.05.1948; 6 Briefe zwsichen Charles E. Merriam und Max Horkheimer, 1940-1941; 4 Briefe zwischen Josef Messinger und Max Horkheimer, 1940; 1 Curriculum Vitae von Alfred Meusel an Max Horkheimer; 1 Brief von Max Horkheimer an Gerhard Meyer, 17.10.1938; 3 Briefe zwischen Hans A. Meyer und Max Horkheimer´09.10.1939, 1947; 2 Briefe zwischen Julie Meyer und Max Horkheimer, 12.04.1941, 15.04.1941; 43 Briefe zwischen Hermann Meyer-Lindenberg, Oscar Meyer und Max Horkheimer sowie Briefwechsel mit Hadley Cantril; 2 Briefe zwischen Hadley Cantril und Theodor W. Adorno, 22.05.1941, 28.05.1941; 1 Brief von Jerome Michael an Margot von Mendelssohn, 10.01.1941; 2 Briefe und 2 Beilagen zwischen Joseph Mire und Max Horkheimer, 16.03.1941, 28.03.1941; 6 Briefe zwischen Mitchell, Silberberg & Knupp, Los Angeles und Max Horkheimer, 1942, 1943; 1 Brief von Friedrich Pollock an Wesley C. Mitchell, 06.08.1940; 3 Briefe zwischen Hans Mohr und Max Horkheimer, 29.03.1946, 1946; 1 Brief von Herbert Moeller Morton an Max Horkheimer, 25.02.1940; 1 Brief von Max Horkheimer an den Chairman of the Committee on General Scholarships, Cambridge Massachusetts, 01.03.1940; 2 Briefe von David H. Moses an Max Horkheimer, 1939; 1 Brief von Franz Neumann an Philip Mosley, 28.04.1941; 49 Briefe zwischen Dorthy I. Mulgrave und Max Horkheimer, 1936-1940; 1 Brief von Max Horkheimer an das Municipal Court, San Francisco, 24.12.1948;
Resumo:
11 Briefe zwischen M. Gosling und Max Horkheimer, 1935-1938; 1 Brief von Ellen Gottschalk an 04.08.1936; 1 Brief von Brill an Max Horkheimer, 15.08.1936; 2 Briefe zwischen Louise Gottschalk und Max Horkheimer, 06.12.1937, 19.04.1937; 3 Briefe zwischen Max Gottschalk und Max Horkheimer, 1941, 23.01.1941; 2 Briefe zwischen Nemes Gottschalk und Max Horkheimer, 29.03.1939, 03.04.1939; 2 Briefe zwischen Lawrence Gould und Max Horkheimer, 12.01.1947, 04.01.1947; 4 Briefe zwischen Isaeque Graeber und Max Horkheimer, 20.07.1941, 1941; 4 Briefe zwischen Malborne W. Graham und Max Horkheimer, 17.10.1940, 1940; 1 Brief von Max Horkheimer an J. A. C. Grant, 23.10.1940; 2 Briefe zwischen dem Grant Grove Lodge Kings Canyon National Park California und Max Horkheimer, 30.09.1946, 04.10.1946; 4 Brefe zwischen Liesel Gras und Max Horkheimer, 1948, 02.04.1948; 2 Briefe zwischen Claire F. Gravel und 23.03.1942, 26.03.1942; 1 Brief und 4 Briefentwürfe von Max Horkheimer an Edward S. Greenbaum, 20.06.1940; 13 Briefe zwischen B. Groethuysen und Max Horkheimer, 1935-1937; 1 Hochzeitsanzeige von Isabelle Grossen, 26.11.1938; 1 Brief von Max Horkheimer an Isabelle Grossen, 17.12.1938; 1 Brief von Kurt Grossmann an Max Horkheimer, 29.12.1939; 3 Briefe von Eva Grosz an Max Horkheimer, 1937; 5 Briefe zwischen Franz M. Groedel und Max Horkheimer, 1939, Oktober 1939; 7 Briefe zwischen Emil Grünberg und Max Horkheimer, 1935-1940; 1 Brief von B. M. Telders an Max Horkheimer, 27.09.1938; 3 Briefe zwischen dem Academic Assistance Council London und Max Horkheimer, 1935, 29.03.1935; 1 Briefentwurft von Max Horkheimer an Karl Grünberg, 07.02.1936; 1 Brief von Juliette Favez an Max Horkheimer, 07.02.1936; 3 Briefe zwsichen Martin Grünberg und Max Horkheimer, November 1938, 18.11.1938; 3 Briefe zwischen Alfred Grünebaum und Max Horkheimer, 10.01.1939, 1939; 2 Briefe zwischen D. E. Grünebaum und Max Horkheimer, 24.11.1940, 02.12.1940; 3 Briefe zwischen Richard Güldenstein und Max Horkheimer, August 1937, 17.08.1937; 1 Brief von Daniel Guérin an Max Horkheimer, 13.07.1947; 1 Brief von Max Horkheimer an Guerro, 08.09.1936;